Susquehanna International Group
IMNM icon

Susquehanna International Group’s Immunome IMNM Stock Holding History

Susquehanna International Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.03M Sell
138,500
-82,400
-37% -$1.83M ﹤0.01% 5246
2025
Q4 		$4.74M Buy
220,900
+165,600
+299% +$2.91M ﹤0.01% 4106
2025
Q3 		$648K Buy
55,300
+7,600
+16% +$75.6K ﹤0.01% 8382
2025
Q2 		$444K Sell
47,700
-1,214,300
-96% -$9.96M ﹤0.01% 9451
2025
Q1 		$8.49M Buy
1,262,000
+1,225,600
+3,367% +$11.8M ﹤0.01% 2749
2024
Q4 		$387K Buy
36,400
+5,700
+19% +$68.9K ﹤0.01% 9286
2024
Q3 		$449K Sell
30,700
-12,100
-28% -$172K ﹤0.01% 8725
2024
Q2 		$518K Buy
42,800
+23,300
+119% +$364K ﹤0.01% 8176
2024
Q1 		$481K Buy
+19,500
New +$396K ﹤0.01% 8609
2023
Q4 		– Sell
-17,100
Closed -$143K – 12800
2023
Q3 		$143K Sell
17,100
-3,500
-17% -$25.7K ﹤0.01% 10598
2023
Q2 		$163K Buy
20,600
+1,400
+7% +$7.66K ﹤0.01% 10487
2023
Q1 		$95.8K Buy
+19,200
New +$93.9K ﹤0.01% 11330
2022
Q2 		– Sell
-18,300
Closed -$104K – 13374
2022
Q1 		$104K Sell
18,300
-12,800
-41% -$95.7K ﹤0.01% 11875
2021
Q4 		$403K Sell
31,100
-500
-2% -$8.92K ﹤0.01% 9750
2021
Q3 		$769K Buy
+31,600
New +$551K ﹤0.01% 8238

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Susquehanna International Group's IMNM Position: Q1 2026 in Review

Susquehanna International Group reduced its Immunome (IMNM) stake by 65% in Q1 2026, selling an estimated $2.49M and leaving 58,985 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #7248.

Susquehanna International Group first reported a position in IMNM in Q3 2021 and has held it in 18 quarters since. The position peaked at $9.27M in Q1 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Susquehanna International Group held 58,985 shares of Immunome worth $1.29M as of Q1 2026.
  • Susquehanna International Group sold 111,929 Immunome shares in Q1 2026, an estimated $2.49M.
  • Immunome made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7248 holding.
  • Susquehanna International Group first reported a position in Immunome in Q3 2021 and has held it in 18 quarters since.
  • Susquehanna International Group's Immunome position peaked at $9.27M in Q1 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.